Arthroscopic Stabilization vs Latarjet Procedure for Shoulder Dislocation
Trial Summary
What is the purpose of this trial?
The primary objective of the pilot study is to assess the feasibility of a definitive trial to determine the effect of arthroscopic capsuloligamentous repair (Bankart + Remplissage) vs. coracoid transfer (Latarjet procedure) on recurrent dislocation rates and functional outcomes over a 24-month period.
Do I have to stop taking my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
Is the Latarjet procedure generally safe for shoulder dislocation treatment?
The Latarjet procedure is generally considered safe, with studies showing no screw-related or neurovascular complications, although some patients may experience mild joint wear over time. It is less invasive than some alternatives and has a low rate of recurrent instability, but there can be a slight decrease in shoulder rotation range.12345
How does the Arthroscopic Stabilization vs Latarjet Procedure for Shoulder Dislocation treatment differ from other treatments?
This treatment is unique because it combines the Bristow-Latarjet procedure with a Bankart repair, providing a triple blocking effect to stabilize the shoulder. It addresses bone loss and capsular deficiency, offering a nearly anatomic shoulder repair and extending surgical options for patients with recurrent shoulder instability.46789
Research Team
Moin Khan, MD
Principal Investigator
McMaster University
Eligibility Criteria
This trial is for adults aged 18-50 with a history of recurrent shoulder dislocation, specifically anterior dislocation confirmed by physical exam or imaging. Candidates should have mild glenoid bone loss and be able to give informed consent. It's not for those with previous shoulder surgery, epilepsy, other shoulder injuries like cuff tears, multidirectional instability, pregnancy, or certain connective tissue disorders.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo either the Bankart + Remplissage Procedure or the Latarjet Procedure
Post-operative Recovery
Participants recover from surgery with a sling for 4 weeks and are restricted from sports for 6 months
Follow-up
Participants are monitored for recurrent dislocation rates and functional outcomes
Treatment Details
Interventions
- Bankart + Remplissage Procedure
- Latarjet Procedure
Bankart + Remplissage Procedure is already approved in European Union, United States, Canada for the following indications:
- Recurrent shoulder dislocations
- Anterior shoulder instability
- Recurrent shoulder dislocations
- Anterior shoulder instability
- Recurrent shoulder dislocations
- Anterior shoulder instability
Find a Clinic Near You
Who Is Running the Clinical Trial?
Moin Khan
Lead Sponsor
University of Michigan
Collaborator
Campus Bio-Medico University
Collaborator
OLVG
Collaborator
Hospital Universitario La Paz
Collaborator
Endeavor Health
Collaborator
Kingston Health Sciences Centre
Collaborator
Queen's University
Collaborator
University of Western Ontario, Canada
Collaborator
The Ottawa Hospital
Collaborator